{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:06:47Z","timestamp":1775610407270,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["230k"],"award-info":[{"award-number":["230k"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10067-024-06920-9","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T06:02:20Z","timestamp":1709532140000},"page":"1623-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune profiling analysis of double-negative T cells in patients with systemic sclerosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Dongdong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihribangvl","family":"Alip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinran","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-0668","authenticated-orcid":false,"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"10103","key":"6920_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/s0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699. https:\/\/doi.org\/10.1016\/s0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"6920_CR2","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP et al (2015) Systemic sclerosis. Nat Rev Dis Primers 1:15002. https:\/\/doi.org\/10.1038\/nrdp.2015.2","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"6920_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8(3):304\u2013320. https:\/\/doi.org\/10.1016\/s2213-2600(19)30480-1","journal-title":"Lancet Respir Med"},{"issue":"16","key":"6920_CR4","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1080\/14656566.2020.1793960","volume":"21","author":"ZH McMahan","year":"2020","unstructured":"McMahan ZH, Volkmann ER (2020) An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis. Expert Opin Pharmacother 21(16):2041\u20132056. https:\/\/doi.org\/10.1080\/14656566.2020.1793960","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"6920_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/clim.2002.5225","volume":"104","author":"JJ Bleesing","year":"2002","unstructured":"Bleesing JJ, Brown MR, Novicio C, Guarraia D, Dale JK, Straus SE et al (2002) A composite picture of TcR alpha\/beta(+) CD4(-)CD8(-) T Cells (alpha\/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immunol 104(1):21\u201330. https:\/\/doi.org\/10.1006\/clim.2002.5225","journal-title":"Clin Immunol"},{"issue":"12","key":"6920_CR6","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","volume":"181","author":"JC Crispin","year":"2008","unstructured":"Crispin JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE et al (2008) Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 181(12):8761\u20136. https:\/\/doi.org\/10.4049\/jimmunol.181.12.8761","journal-title":"J Immunol"},{"key":"6920_CR7","doi-asserted-by":"publisher","unstructured":"H Li and G C Tsokos (2020) Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol Publish Ahead of DOI: https:\/\/doi.org\/10.1097\/bor.0000000000000778.","DOI":"10.1097\/bor.0000000000000778"},{"issue":"11","key":"6920_CR8","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.4049\/jimmunol.167.11.6188","volume":"167","author":"JJ Priatel","year":"2001","unstructured":"Priatel JJ, Utting O, Teh HS (2001) TCR\/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 167(11):6188\u201394. https:\/\/doi.org\/10.4049\/jimmunol.167.11.6188","journal-title":"J Immunol"},{"issue":"6","key":"6920_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/eji.201546056","volume":"46","author":"N Rodr\u00edguez-Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez-Rodr\u00edguez N, Apostolidis SA, Fitzgerald L, Meehan BS, Corbett AJ, Mart\u00edn-Villa JM et al (2016) Pro-inflammatory self-reactive T cells are found within murine TCR-\u03b1\u03b2(+) CD4(-) CD8(-) PD-1(+) cells. Eur J Immunol 46(6):1383\u201391. https:\/\/doi.org\/10.1002\/eji.201546056","journal-title":"Eur J Immunol"},{"issue":"2","key":"6920_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2012-201511","volume":"72","author":"A Alunno","year":"2013","unstructured":"Alunno A, Bistoni O, Bartoloni E, Caterbi S, Bigerna B, Tabarrini A et al (2013) IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren\u2019s syndrome. Ann Rheum Dis 72(2):286\u201392. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201511","journal-title":"Ann Rheum Dis"},{"key":"6920_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.01.014","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang Y, Wu Y, Feng M, Zhao X, Gao C et al (2021) Double-negative T cells are absolutely elevated in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis. Mol Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2021.01.014","journal-title":"Mol Immunol"},{"issue":"12","key":"6920_CR12","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1073\/pnas.1814394116","volume":"116","author":"H Meng","year":"2019","unstructured":"Meng H, Zhao H, Cao X, Hao J, Zhang H, Liu Y et al (2019) Double-negative T cells remarkably promote neuroinflammation after ischemic stroke. Proc Natl Acad Sci 116(12):5558\u20135563. https:\/\/doi.org\/10.1073\/pnas.1814394116","journal-title":"Proc Natl Acad Sci"},{"key":"6920_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2017.06.002","volume":"181","author":"D Brandt","year":"2017","unstructured":"Brandt D, Sergon M, Abraham S, Mabert K, Hedrich CM (2017) TCR(+)CD3(+)CD4(-)CD8(-) effector T cells in psoriasis. Clin Immunol 181:51\u201359. https:\/\/doi.org\/10.1016\/j.clim.2017.06.002","journal-title":"Clin Immunol"},{"issue":"1","key":"6920_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4049\/jimmunol.143.1.103","volume":"143","author":"S Shivakumar","year":"1989","unstructured":"Shivakumar S, Tsokos GC, Datta SK (1989) T cell receptor alpha\/beta expressing double-negative (CD4-\/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143(1):103\u201312","journal-title":"J Immunol"},{"issue":"7","key":"6920_CR15","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood-2004-07-2583","volume":"105","author":"K Fischer","year":"2005","unstructured":"Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M et al (2005) Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105(7):2828\u201335. https:\/\/doi.org\/10.1182\/blood-2004-07-2583","journal-title":"Blood"},{"issue":"1","key":"6920_CR16","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1038\/s41467-019-12243-0","volume":"10","author":"D Tian","year":"2019","unstructured":"Tian D, Yang L, Wang S, Zhu Y, Shi W, Zhang C et al (2019) Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma. Nat Commun 10(1):4246. https:\/\/doi.org\/10.1038\/s41467-019-12243-0","journal-title":"Nat Commun"},{"issue":"1","key":"6920_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41467-021-20941-x","volume":"12","author":"G Sun","year":"2021","unstructured":"Sun G, Zhao X, Li M, Zhang C, Jin H, Li C et al (2021) CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis. Nat Commun 12(1):650. https:\/\/doi.org\/10.1038\/s41467-021-20941-x","journal-title":"Nat Commun"},{"issue":"7","key":"6920_CR18","doi-asserted-by":"publisher","first-page":"e11427","DOI":"10.1371\/journal.pone.0011427","volume":"5","author":"B Duncan","year":"2010","unstructured":"Duncan B, Nazarov-Stoica C, Surls J, Kehl M, Bona C, Casares S et al (2010) Double negative (CD3+ 4\u20138-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. PLoS One 5(7):e11427. https:\/\/doi.org\/10.1371\/journal.pone.0011427","journal-title":"PLoS One"},{"issue":"1","key":"6920_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/35095500","volume":"1","author":"G Anderson","year":"2001","unstructured":"Anderson G, Jenkinson EJ (2001) Lymphostromal interactions in thymic development and function. Nat Rev Immunol 1(1):31\u201340. https:\/\/doi.org\/10.1038\/35095500","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"6920_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nri913","volume":"2","author":"H Spits","year":"2002","unstructured":"Spits H (2002) Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2(10):760\u201372. https:\/\/doi.org\/10.1038\/nri913","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"6920_CR21","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.4049\/jimmunol.162.10.5747","volume":"162","author":"PF Mixter","year":"1999","unstructured":"Mixter PF, Russell JQ, Morrissette GJ, Charland C, Aleman-Hoey D, Budd RC (1999) A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals. J Immunol 162(10):5747\u201356","journal-title":"J Immunol"},{"issue":"9","key":"6920_CR22","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1182\/blood-2006-10-050625","volume":"109","author":"D Zhang","year":"2007","unstructured":"Zhang D, Yang W, Degauque N, Tian Y, Mikita A, Zheng XX (2007) New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109(9):4071\u20139. https:\/\/doi.org\/10.1182\/blood-2006-10-050625","journal-title":"Blood"},{"key":"6920_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2012.07.010","volume":"40","author":"EE Hillhouse","year":"2013","unstructured":"Hillhouse EE, Lesage S (2013) A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J Autoimmun 40:58\u201365. https:\/\/doi.org\/10.1016\/j.jaut.2012.07.010","journal-title":"J Autoimmun"},{"key":"6920_CR24","doi-asserted-by":"publisher","unstructured":"M E Maccari, S Fuchs, P Kury, G Andrieux, S V\u00f6lkl, B Bengsch, et al. (2021) A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS. J Exp Med 218(2). https:\/\/doi.org\/10.1084\/jem.20192191","DOI":"10.1084\/jem.20192191"},{"issue":"11","key":"6920_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u201355. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6920_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P et al (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76(1):270\u2013276. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209768","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6920_CR27","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-020-16636-4","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Adamopoulos IE, Moulton VR, Stillman IE, Herbert Z, Moon JJ et al (2020) Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun 11(1):2859. https:\/\/doi.org\/10.1038\/s41467-020-16636-4","journal-title":"Nat Commun"},{"issue":"5","key":"6920_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R F\u00f6rster","year":"2008","unstructured":"F\u00f6rster R, Davalos-Misslitz AC, Rot A (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8(5):362\u201371. https:\/\/doi.org\/10.1038\/nri2297","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"6920_CR29","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/art.40534","volume":"70","author":"A-M Hoffmann-Vold","year":"2018","unstructured":"Hoffmann-Vold A-M, Hesselstrand R, Fretheim H, Ueland T, Andreassen AK, Brunborg C et al (2018) CCL21 as a potential serum biomarker for pulmonary arterial hypertension in systemic sclerosis. Arthritis Rheumatol (Hoboken, NJ) 70(10):1644\u20131653. https:\/\/doi.org\/10.1002\/art.40534","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"10","key":"6920_CR30","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","volume":"73","author":"AL Mathes","year":"2014","unstructured":"Mathes AL, Christmann RB, Stifano G, Affandi AJ, Radstake TR, Farina GA et al (2014) Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. Ann Rheum Dis 73(10):1864\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202814","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6920_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.30249","volume":"69","author":"A Ambade","year":"2019","unstructured":"Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y et al (2019) Pharmacological Inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice. Hepatology 69(3):1105\u20131121. https:\/\/doi.org\/10.1002\/hep.30249","journal-title":"Hepatology"},{"issue":"610","key":"6920_CR32","doi-asserted-by":"publisher","first-page":"eabd8995","DOI":"10.1126\/scitranslmed.abd8995","volume":"13","author":"KJ Gellatly","year":"2021","unstructured":"Gellatly KJ, Strassner JP, Essien K, Refat MA, Murphy RL, Coffin-Schmitt A et al (2021) scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T(reg) function. Sci Transl Med 13(610):eabd8995. https:\/\/doi.org\/10.1126\/scitranslmed.abd8995","journal-title":"Sci Transl Med"},{"issue":"11","key":"6920_CR33","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1084\/jem.20060956","volume":"203","author":"E Yurchenko","year":"2006","unstructured":"Yurchenko E, Tritt M, Hay V, Shevach EM, Belkaid Y, Piccirillo CA (2006) CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med. 203(11):2451\u201360. https:\/\/doi.org\/10.1084\/jem.20060956","journal-title":"J Exp Med."},{"issue":"12","key":"6920_CR34","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1158\/1535-7163.Mct-17-0341","volume":"16","author":"CE de Oliveira","year":"2017","unstructured":"de Oliveira CE, Gasparoto TH, Pinheiro CR, Am\u00f4r NG, Nogueira MRS, Kaneno R et al (2017) CCR5-dependent homing of T regulatory cells to the tumor microenvironment contributes to skin squamous cell carcinoma development. Mol Cancer Ther. 16(12):2871\u20132880. https:\/\/doi.org\/10.1158\/1535-7163.Mct-17-0341","journal-title":"Mol Cancer Ther."},{"key":"6920_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.immunol.16.1.523","volume":"16","author":"MM Davis","year":"1998","unstructured":"Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B et al (1998) Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16:523\u201344. https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.523","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"6920_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","volume":"17","author":"D Brandt","year":"2018","unstructured":"Brandt D, Hedrich CM (2018) TCR\u03b1\u03b2(+)CD3(+)CD4(-)CD8(-) (double negative) T cells in autoimmunity. Autoimmun Rev 17(4):422\u2013430. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.001","journal-title":"Autoimmun Rev"},{"issue":"3","key":"6920_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/icb.2014.99","volume":"93","author":"MN Martina","year":"2015","unstructured":"Martina MN, Noel S, Saxena A, Rabb H, Hamad AR (2015) Double negative (DN) \u03b1\u03b2 T cells: misperception and overdue recognition. Immunol Cell Biol 93(3):305\u201310. https:\/\/doi.org\/10.1038\/icb.2014.99","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"6920_CR38","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/jlb.2mr1219-233r","volume":"107","author":"A Morath","year":"2020","unstructured":"Morath A, Schamel WW (2020) \u03b1\u03b2 and \u03b3\u03b4 T cell receptors: Similar but different. J Leukoc Biol 107(6):1045\u20131055. https:\/\/doi.org\/10.1002\/jlb.2mr1219-233r","journal-title":"J Leukoc Biol"},{"issue":"4","key":"6920_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/cr.2017.11","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Wang D, Moshaverinia A, Liu D, Kou X, Yu W et al (2017) Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res 27(4):559\u2013577. https:\/\/doi.org\/10.1038\/cr.2017.11","journal-title":"Cell Res"},{"issue":"3","key":"6920_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva M, O\u2019Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10(3):170\u201381. https:\/\/doi.org\/10.1038\/nri2711","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"6920_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","volume":"17","author":"D Brandt","year":"2018","unstructured":"Brandt D, Hedrich CM (2018) TCR\u03b1\u03b2 + CD3 + CD4 \u2212 CD8 \u2212 (double negative) T cells in autoimmunity. Autoimmunity Reviews 17(4):422\u2013430. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.001","journal-title":"Autoimmunity Reviews"},{"issue":"7","key":"6920_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.14740\/jocmr3849","volume":"11","author":"S Wangkaew","year":"2019","unstructured":"Wangkaew S, Prasertwittayakij N, Euathrongchit J (2019) Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles. J Clin Med Res 11(7):524\u2013531. https:\/\/doi.org\/10.14740\/jocmr3849","journal-title":"J Clin Med Res"},{"issue":"3","key":"6920_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/bor.0000000000000795","volume":"33","author":"D Roofeh","year":"2021","unstructured":"Roofeh D, Lescoat A, Khanna D (2021) Treatment for systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol 33(3):240\u2013248. https:\/\/doi.org\/10.1097\/bor.0000000000000795","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"6920_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201(6):650\u2013660. https:\/\/doi.org\/10.1164\/rccm.201903-0563CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"6920_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41584-022-00803-6","volume":"18","author":"R Lafyatis","year":"2022","unstructured":"Lafyatis R, Valenzi E (2022) Assessment of disease outcome measures in systemic sclerosis. Nat Rev Rheumatol 18(9):527\u2013541. https:\/\/doi.org\/10.1038\/s41584-022-00803-6","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"6920_CR46","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3899\/jrheum.090919","volume":"37","author":"JG Walker","year":"2010","unstructured":"Walker JG, Steele RJ, Schnitzer M, Taillefer S, Baron M, Hudson M (2010) The association between disease activity and duration in systemic sclerosis. J Rheumatol 37(11):2299\u2013306. https:\/\/doi.org\/10.3899\/jrheum.090919","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06920-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:06:31Z","timestamp":1715587591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06920-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6920"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06920-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}